| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001098470A3 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001096370A3 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | WO2001083819A9 Methods for designing exogenous regulatory molecules |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | WO2001081632A9 Methods for monitoring the expression of alternatively spliced genes |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081551A8 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001075452A9 Detection of nerve damage using marker scip |
| 01/03/2003 | WO2001073087A8 Cestrum yellow leaf curling virus promoters |
| 01/03/2003 | WO2001064899A8 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 01/03/2003 | WO2001064891A9 Nucleotide sequences for embryo and/or endosperm specific expression in plants |
| 01/03/2003 | WO2001062959A3 Endometriosis-related markers and uses thereof |
| 01/03/2003 | WO2001057272A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 01/03/2003 | WO2001057251A3 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 01/03/2003 | WO2001053502A9 Root-preferred promoter elements and methods of use |
| 01/03/2003 | WO2001034902A3 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 01/03/2003 | CA2790034A1 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2724316A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724188A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724166A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2724158A1 Defensin polynucleotides and methods of use |
| 01/03/2003 | CA2677781A1 Nitrilases |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2460809A1 Polynucleotide vaccine |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452602A1 Compositions and methods for modulating plant development |
| 01/03/2003 | CA2452088A1 Compositions and methods for intracellular delivery |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451974A1 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451654A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | CA2451493A1 Cell growth inhibitors containing anti-glypican 3 antibody |
| 01/03/2003 | CA2451486A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | CA2451437A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | CA2451380A1 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451311A1 Stimulation of vascularization with vegf-b |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451266A1 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 01/03/2003 | CA2451250A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | CA2451247A1 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | CA2451239A1 Antibodies against tumor-associated antigenic taget (tat) polypeptides |
| 01/03/2003 | CA2451222A1 Configurable dynamic three dimensional array |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450792A1 Homoaconitase as a target for fungicides |
| 01/03/2003 | CA2450783A1 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | CA2450580A1 Method for the determination of telomere length |
| 01/03/2003 | CA2450577A1 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 01/03/2003 | CA2450479A1 Method for detecting diseases caused by chromosomal imbalances |
| 01/03/2003 | CA2447249A1 Abin-mediated hepatitis protection |
| 01/03/2003 | CA2446218A1 Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| 01/03/2003 | CA2427798A1 Testis protein, zsig86 |
| 01/02/2003 | US20030005487 Detection of plants with amplified chaperone activity; obtain plant, heat plant, monitor expression of chaperone proteins in cells |
| 01/02/2003 | US20030005485 Nucleotide sequences coding polypeptide for use the generation of disease resistant plants |
| 01/02/2003 | US20030005484 Microbiocidal and pesticidal aromatic aldehydes |
| 01/02/2003 | US20030005482 Nucleotide sequences coding enzymatic polypeptide for use in the generation of stress and disease resistant plants |
| 01/02/2003 | US20030005481 Reduction of lignification in vascular plants; obtain cell, transfrom with nucleotides sequences coding proteins associated with lignin biosynthesis, propagate and monitor expression in plants |
| 01/02/2003 | US20030005480 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 01/02/2003 | US20030005478 Methods |
| 01/02/2003 | US20030005477 Transgenic mice containing beta3GalT2 gene disruptions |
| 01/02/2003 | US20030005476 Transgenic rodent for as tool in he diagnosis and treatment of nervous system disorders and epilepsy |
| 01/02/2003 | US20030005475 Transgenic mice containing acylphosphatase gene disruptions |
| 01/02/2003 | US20030005474 Transgenic rodent for use as tool in the diagnosis and treatment of nervous system disorders |
| 01/02/2003 | US20030005473 Transgenic rodent for use as a model in the treatment of nervous system disorders |
| 01/02/2003 | US20030005472 Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression |
| 01/02/2003 | US20030005470 Animal model for use in the diagnosis and treatment of tumors and bone matastasis |
| 01/02/2003 | US20030005468 Methods and vectors for improving nucleic acid expression |
| 01/02/2003 | US20030004329 Gene-trap identification of host cell proteins required for hepatitis C virus replication |
| 01/02/2003 | US20030004328 Controlling phosphorylation |
| 01/02/2003 | US20030004327 Cerebellum and embryo specific protein |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004323 Novel antigen constructs useful in the detection and differention of antibodies to hiv |
| 01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004309 Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004123 Targeted gene transfer using G protein coupled receptors |
| 01/02/2003 | US20030004122 Anticancer agents |
| 01/02/2003 | US20030004120 Apoptosis; antitumor, anticancer agents |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004091 Medicinal combination useful for in vivo exogenic transfection and expression |
| 01/02/2003 | US20030003609 Ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 01/02/2003 | US20030003597 Diagnosing pregnancy in humans; obtain sample, incubate with antibody, monitor complex formation, presence of complex indicates pregnancy |
| 01/02/2003 | US20030003585 Expression vector for use generation of genetically engineerercd plants |
| 01/02/2003 | US20030003584 Liposomal vector binding protein for hepatocyte DNA delivery |
| 01/02/2003 | US20030003583 Regulation of transgene expression following AAV transduction |
| 01/02/2003 | US20030003582 Trans-viral vector mediated gene transfer to the retina |